Potentials and challenges of Levodopa particle formulation for treatment of Parkinson's disease through intranasal and pulmonary delivery

• المؤلفون الرئيسيون: Paul, Mahasweta, Lau, Raymond
• مؤلفون آخرون: School of Chemical and Biomedical Engineering
• التنسيق: مقال
• اللغة: English
• منشور في: 2022
• الموضوعات: Engineering::Bioengineering; Particle Characterization; Inhalation Drug Delivery
• الوصول للمادة أونلاين: https://hdl.handle.net/10356/160960
• المؤسسة: Nanyang Technological University

Inhalation drug delivery has gained interests in delivery of Levodopa for the treatment of Parkinson's disease. In comparison to traditional oral delivery, delivery via intranasal or pulmonary pathways allows a slower drug degradation, greater drug bioavailability, increased blood plasma concen...